Journal
STRUCTURE
Volume 27, Issue 9, Pages 1427-+Publisher
CELL PRESS
DOI: 10.1016/j.str.2019.06.010
Keywords
-
Funding
- NIH [GM58670, CA172886, RR25528, RR028976]
- US Department of Defense [DoD W81XWH-17-1-0429]
- University of Pittsburgh Vascular Medicine Institute
- CPRIT [RP1450105]
- AHA [15PRE25550015]
- CONACYT [254046]
- NIGMS [P41GM103311]
- Office of the Vice President for Research [NIH P30 CA054174]
- Mays Cancer Center [NIH P30 CA054174]
Ask authors/readers for more resources
Betaglycan (BG) and endoglin (ENG), homologous co-receptors of the TGF-beta family, potentiate the signaling activity of TGF-beta 2 and inhibin A, and BMP-9 and BMP-10, respectively. BG exists as monomer and forms 1:1 growth factor (GF) complexes, while ENG exists as a dimer and forms 2:1 GF complexes. Herein, the structure of the BG orphan domain (BG(O)) reveals an insertion that blocks the region that the endoglin orphan domain (ENG(O)) uses to bind BMP-9, preventing it from binding in the same manner. Using binding studies with domain-deleted forms of TGF-beta and BG(O), as well as small-angle X-ray scattering data, BG(O) is shown to bind its cognate GF in an entirely different manner compared with ENG(O). The alternative interfaces likely engender BG and ENG with the ability to selectively bind and target their cognate GFs in a unique temporal-spatial manner, without interfering with one another or other TGF-beta family GFs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available